Johnson & Johnson (JNJ.N) CEO: The company will focus on early-stage deals in 2026, but "has sufficient financial strength to capitalize on opportunities."

2026-01-13

Johnson & Johnson (JNJ.N) CEO: The company will focus on early-stage deals in 2026, but "has sufficient financial strength to capitalize on opportunities."